Armenia vs Cuba: Treatment success rate for patients treated for MDR-TB
Armenia
68.0%
in 2022
Cuba
67.0%
in 2022
Armenia rank
104th
Cuba rank
106th
Treatment success rate for patients treated for MDR-TB over time
- Armenia
- Cuba
How they compare
Armenia currently reports 68.0% against 67.0% in Cuba, a difference of 1.0%.
The two have swapped places 7 times across 15 shared years of data; in 2008 it was Cuba ahead.
Armenia ranks 104th and Cuba ranks 106th of 163 countries.
Across the 3 decades both report, Armenia averaged higher in 1 and Cuba in 2.
Head to head by decade
| Decade | Armenia | Cuba | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.0% | 66.5% | 13.5% | Cuba |
| 2010s | 48.2% | 56.7% | 8.5% | Cuba |
| 2020s | 67.3% | 58.0% | 9.3% | Armenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Armenia or Cuba?
- Armenia, at 68.0% against 67.0% in Cuba as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Armenia and Cuba?
- 1.0%, with Armenia ahead.
- How many years of comparable data are there for Armenia and Cuba?
- 15 years are reported by both, from 2008 to 2022.
- How do Armenia and Cuba rank globally for treatment success rate for patients treated for mdr-tb?
- Armenia ranks 104th and Cuba ranks 106th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.